GoodRx Holdings (GDRX) Acquisitions (2020 - 2025)

GoodRx Holdings has disclosed Acquisitions across 4 years of filings, most recently posting $13.4 million for Q4 2025.

• In Q4 2025, Acquisitions changed N/A year-over-year to $13.4 million; the TTM figure through Jun 2026 stood at $13.4 million (down 55.2% YoY), while the FY2025 annual figure was $43.4 million, changed N/A from the prior year.
• Acquisitions came in at $13.4 million for Q4 2025 at GoodRx Holdings, down from $30.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $149.9 million in Q2 2022 to a low of $7.0 million in Q1 2022.
• Average Acquisitions over 3 years is $56.8 million, with a median of $22.3 million recorded in 2021.
• Year-over-year, Acquisitions slumped 73.94% in 2021 and grew 19.21% in 2022.
• Over 3 years, Acquisitions stood at $14.5 million in 2021, then jumped by 930.79% to $149.9 million in 2022, then sank by 91.03% to $13.4 million in 2025.
• Per Business Quant data, the three most recent Acquisitions figures were $13.4 million in Q4 2025, $30.0 million in Q1 2025, and $149.9 million in Q2 2022.